The ultra-long-action profile of this insulin is mainly attributable to the formation of soluble multihexamers at the injection site, resulting in stable pharmacokinetics.

Judicious choice of pharmacotherapy with an insulin regimen that offers more physiologic and predictable time-action profiles than traditional human basal insulin can lower nocturnal hypoglycemia ...

Research and Markets: Insulin Resistance Therapeutics Pipeline Review 2015 - 10 Companies & 20 Drug Profiles March 03, 2015 08:24 AM Eastern Standard Time ...